Antigen analogs as therapeutic agents
The immune system’s function is to protect us against invading pathogens such as viruses, bacteria, parasites, and even the runaway growth of cancer cells. T lymphocytes play a major role in these immune responses, and in most cases the outcome is beneficial, such as killing infected cells or helping B-cells produce antibodies. In many cases, medical science has been capable of augmenting or enhancing the beneficial immune responses. Successes are numerous. Vaccines are now available against viral diseases such as influenza, hepatitis, and polio, and against bacterial infections such as diptheria, whooping cough, and tetanus. Clearly, however, much more progress is required in developing vaccines efficacious against diseases such as cancer and AIDS.
KeywordsExperimental Autoimmune Encephalomyelitis Myelin Basic Protein Major Histocompatibility Complex Type Affinity Threshold Inhibit Antigen Presentation
Unable to display preview. Download preview PDF.
- L. Adorini, J-C. Guéry, G. Rodriguez-Tarduchy, and S. Trembleau, Selective immunosuppression, Immunol. TodayJ4:285 (1993).Google Scholar
- 17.D.E. Smilek, D.C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman, and H.O. McDevitt, A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis, Proc. Natl Acad. Sci. USA88:9633 (1991).PubMedCrossRefGoogle Scholar
- 18.K. Snoke, J. Alexander, A. Franco, L. Smith, J.V. Brawley, P.O. Concannon, H.M. Grey, A. Sette, and P. Wentworth, The inhibition of different T-cell lines specific for the same antigen with TCR antagonist peptides, J. Immunol.151:1 (1993).Google Scholar
- H. Pircher, U.H. Rohrer, D. Moskophidis, R.M. Zinkernagel, and H. Hengartner, Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature351:482 (1991). 117Google Scholar